Abstract. We present a study of the stellar parameters, distances and spectral energy distributions (SEDs) of HD 34282 and HD 141569, two pre-main sequence Herbig AeBe stars. Both objects have been reported to show "anomalous positions" in the HR diagram in the sense that they appear below the main sequence. A significant result of this work is that both stars are metal-deficient. The Hipparcos distance of HD 34282 is very uncertain and the current study places the star at the expected evolutionary position in the HR diagram, i.e. as a PMS star. The distance for HD 141569 found in this work matches the Hipparcos distance, and the problem of its anomalous position is solved as a result of the low metallicity of the object: using the right metallicity tracks, the star is in the PMS region. The SEDs are constructed using data covering ultraviolet to millimetre wavelengths. Physical, non-parametric models, have been applied in order to extract some properties of the disks surrounding the stars. The disk around HD 34282 is accreting actively, it is massive and presents large grains in the mid-plane and small grains in the surface. HD 141569 has a very low mass disk, which is in an intermediate stage towards a debris-type disk.
Coordinated UV and visual observations of 59 Cyg in 1978–81 show strong mass ejection activity and strong variability in displacements and profiles of superionized lines during the new Be phase, starting from a “quasi normal B” phase in 1977, and increasing irregularly through 1981 to a low and then moderate Hα emission. These data show that visual data alone cannot describe the activity of the star.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.